Matrix Bio is a pioneering research venture with a focus on harnessing the anti-cancer and pro-longevity properties of high molecular weight hyaluronic acid for human health benefits. The company has partnered with VitaDAO and the Gorbunova Laboratory to advance its research in this innovative field. With its headquarter in the United States, Matrix Bio aims to revolutionize the approach to cancer treatment and aging-related issues through groundbreaking discoveries in hyaluronic acid. For further information, interested parties can contact the company via [email protected]. This unique venture presents an exciting opportunity for potential investors and those vested in advancing medical research and the fight against cancer.
There is no investment information
No recent news or press coverage available for Matrix Bio.